Published in BMJ on August 12, 2000
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85
Standards of medical care in diabetes--2010. Diabetes Care (2010) 24.28
Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66
Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
Collaborative care for patients with depression and chronic illnesses. N Engl J Med (2010) 8.92
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA (2010) 5.06
Use of ramipril in preventing stroke: double blind randomised trial. BMJ (2002) 4.91
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med (2012) 2.75
Tracking diabetes: New York City's A1C Registry. Milbank Q (2009) 2.34
Community Outreach and Cardiovascular Health (COACH) Trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Circ Cardiovasc Qual Outcomes (2011) 2.12
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med (2010) 2.06
Encounter frequency and blood pressure in hypertensive patients with diabetes mellitus. Hypertension (2010) 2.02
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney Int (2011) 1.91
Blood pressure and stroke risk among diabetic patients. J Clin Endocrinol Metab (2013) 1.79
Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation (2009) 1.77
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Cardiovasc Diabetol (2014) 1.75
Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Serv Res (2006) 1.65
Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscle. Circ Res (2007) 1.52
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest (2004) 1.50
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes (2014) 1.44
Diabetic nephropathy. Diabetol Metab Syndr (2009) 1.43
Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc (2011) 1.43
HbA1c and all-cause mortality risk among patients with type 2 diabetes. Int J Cardiol (2015) 1.42
DialBetics: A Novel Smartphone-based Self-management Support System for Type 2 Diabetes Patients. J Diabetes Sci Technol (2014) 1.38
Hypertension and disrupted blood pressure circadian rhythm in type 2 diabetic db/db mice. Am J Physiol Heart Circ Physiol (2008) 1.23
Aggressive blood pressure control increases coronary heart disease risk among diabetic patients. Diabetes Care (2013) 1.21
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol (2009) 1.20
Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial. CMAJ (2005) 1.20
Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study. Cardiovasc Diabetol (2010) 1.17
Simultaneous control of intermediate diabetes outcomes among Veterans Affairs primary care patients. J Gen Intern Med (2006) 1.17
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract (2008) 1.16
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Association of serum calcium with level of blood pressure in type 2 diabetic patients. J Nephropathol (2013) 1.13
Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol (2010) 1.13
Diversity in diabetes care programmes and views on high quality diabetes care: are we in need of a standardized framework? Int J Integr Care (2008) 1.13
Impact of diabetes on cardiovascular disease: an update. Int J Hypertens (2013) 1.13
Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension. J Gen Intern Med (2008) 1.09
Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? Indian J Endocrinol Metab (2016) 1.09
Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes. BMC Health Serv Res (2010) 1.07
Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum. Diabetes Care (2014) 1.07
Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study. Diabetologia (2014) 1.06
Additional impact of concomitant hypertension and osteoarthritis on quality of life among patients with type 2 diabetes in primary care in Germany - a cross-sectional survey. Health Qual Life Outcomes (2009) 1.06
Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. BMC Public Health (2011) 1.05
Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care (2011) 1.05
Inter-arm blood pressure difference in type 2 diabetes: a barrier to effective management? Br J Gen Pract (2009) 1.05
Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients. J Renal Inj Prev (2012) 1.05
Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12). Diabetol Metab Syndr (2011) 1.04
Diabetes & coronary heart disease: current perspectives. Indian J Med Res (2010) 1.03
Peripheral arterial disease in the elderly. Clin Interv Aging (2007) 1.03
New diabetes diagnostic threshold of hemoglobin A(1c) and the 3-year incidence of retinopathy. Diabetes (2012) 1.01
Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. BMC Endocr Disord (2013) 1.00
The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care (2010) 0.99
Sex differences in step count-blood pressure association: a preliminary study in type 2 diabetes. PLoS One (2010) 0.99
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Development of a complex intervention to test the effectiveness of peer support in type 2 diabetes. BMC Health Serv Res (2007) 0.99
Theory-based predictors of multiple clinician behaviors in the management of diabetes. J Behav Med (2013) 0.99
Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol (2013) 0.98
Strategies for initial management of hypertension. Indian J Med Res (2010) 0.98
Control Beliefs and Risk for Death, Stroke and Myocardial Infarction in Middle-aged and Older Adults: An Observational Study. J Gen Intern Med (2015) 0.98
Microalbuminuria in diabetes mellitus. CMAJ (2002) 0.97
Arterial stiffness is associated with diabetic retinopathy in Korean type 2 diabetic patients. J Prev Med Public Health (2011) 0.97
Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies. Can J Cardiol (2006) 0.97
Diabetes and the risk of heart failure. Heart Fail Clin (2011) 0.96
Recent advances in diabetic nephropathy. Postgrad Med J (2004) 0.96
Hypertension in chronic kidney disease: navigating the evidence. Int J Hypertens (2011) 0.95
Using psychological theory to understand the clinical management of type 2 diabetes in Primary Care: a comparison across two European countries. BMC Health Serv Res (2009) 0.95
Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J (2009) 0.95
Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality. J Gen Intern Med (2008) 0.95
Control of risk factors for cardiovascular disease among adults with previously diagnosed type 2 diabetes mellitus: a descriptive study from a middle eastern arab population. Open Cardiovasc Med J (2012) 0.95
Sex differences in the risk of stroke and HbA(1c) among diabetic patients. Diabetologia (2014) 0.95
Health beliefs of African-Caribbean people with type 2 diabetes: a qualitative study. Br J Gen Pract (2007) 0.94
Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J Am Coll Cardiol (2009) 0.94
Nurse-led behavioral management of diabetes and hypertension in community practices: a randomized trial. J Gen Intern Med (2015) 0.92
The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One (2009) 0.92
The management of diabetes. BMJ (2001) 0.92
Does patient education facilitate diabetic patients' possibilities to reach national treatment targets? A national survey in Swedish primary healthcare. Scand J Prim Health Care (2009) 0.91
Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol (2009) 0.91
"Mind the gap!" Evaluation of the performance gap attributable to exception reporting and target thresholds in the new GMS contract: National database analysis. BMC Health Serv Res (2008) 0.91
Peripheral arterial disease of the lower extremities. Arch Med Sci (2012) 0.89
Adherence index based on the AHA 2006 diet and lifestyle recommendations is associated with select cardiovascular disease risk factors in older Puerto Ricans. J Nutr (2011) 0.89
Trends in hypertension prevalence, awareness, treatment and control in an adult type 2 diabetes Spanish population between 2003 and 2009. PLoS One (2014) 0.89
Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus. Proc (Bayl Univ Med Cent) (2007) 0.89
Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J (2012) 0.88
Factors associated with diabetic retinopathy in chinese patients with type 2 diabetes mellitus. Int J Endocrinol (2012) 0.88
Direct association of visit-to-visit HbA1c variation with annual decline in estimated glomerular filtration rate in patients with type 2 diabetes. J Diabetes Metab Disord (2015) 0.88
Hypertension revisited. Can Fam Physician (2012) 0.88
Changes in the perceived epidemiology of primary hyperaldosteronism. Int J Hypertens (2011) 0.87
Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects. Immunology (2005) 0.87
Factors influencing health care utilization in older Hispanics with diabetes along the Texas-Mexico border. Popul Health Manag (2012) 0.87
Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis. Diabetologia (2013) 0.87
Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitus. Am Heart J (2010) 0.87
Regulation of the hyperosmotic induction of aquaporin 5 and VEGF in retinal pigment epithelial cells: involvement of NFAT5. Mol Vis (2015) 0.86
Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials. J Diabetes Complications (2014) 0.86
Impact of community based peer support in type 2 diabetes: a cluster randomised controlled trial of individual and/or group approaches. PLoS One (2015) 0.86
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med (1997) 19.14
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med (1993) 18.15
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med (1991) 12.89
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00
U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes (1995) 8.95
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ (1999) 5.66
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ (1998) 4.95
UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia (1991) 4.50
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med (2000) 4.29
A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med (1991) 3.85
Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia (1996) 3.62
Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care (1995) 3.61
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care (1998) 3.34
Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens (1993) 2.91
Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA (1991) 2.88
Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med (1993) 2.80
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes (1994) 2.67
UK Prospective Diabetes Study (UKPDS). XI: Biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects. Diabet Med (1994) 2.65
Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial. Arch Intern Med (1999) 2.51
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51
Mortality factors in diabetes. A 20 year mortality study. J Occup Med (1975) 2.48
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia (1993) 2.41
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke (1996) 1.97
Hypertension in Diabetes Study. III. Prospective study of therapy of hypertension in type 2 diabetic patients: efficacy of ACE inhibition and beta-blockade. Diabet Med (1994) 1.91
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia (1996) 1.91
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes (1997) 1.64
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J (1997) 1.45
Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol (1978) 1.22
Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol (1988) 1.22
An economic analysis of captopril in the treatment of diabetic nephropathy. The Collaborative Study Group. Diabetes Care (1996) 1.10
Tracking of blood pressure over a 40-year period in the University of Manitoba Follow-up Study, 1948-1988. Am J Epidemiol (1995) 1.09
Low blood pressure and mortality in the elderly: a 6-year follow-up of 18,022 Norwegian men and women age 65 years and older. Epidemiology (1995) 1.02
Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Diabetologia (1999) 1.01
High blood pressure and end-organ damage. J Hypertens Suppl (1996) 1.00
Effect of ACE inhibition on myocardial ischaemia. Eur Heart J (1998) 0.94
Evidence-based medicine and ACE inhibition. J Cardiovasc Pharmacol (1998) 0.93
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (2000) 35.06
Publication bias in clinical research. Lancet (1991) 22.85
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) (2001) 8.45
Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care (1998) 8.29
Metformin. N Engl J Med (1996) 7.66
A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol (Copenh) (1972) 7.64
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) BMJ (1998) 7.48
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55
Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab (1997) 5.84
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med (2005) 3.80
The quality of diabetic care in a London health district. J Epidemiol Community Health (1980) 3.78
Lack of confidence among trainee doctors in the management of diabetes: the Trainees Own Perception of Delivery of Care (TOPDOC) Diabetes Study. QJM (2011) 3.46
The assessment of insulin resistance in man. Diabet Med (2002) 3.35
Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10
Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med (1983) 3.07
Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. BMJ (1998) 3.07
A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia (2004) 3.01
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors. Arch Intern Med (1992) 2.95
United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol (1998) 2.93
Developing a district diabetic register. BMJ (1992) 2.92
Vital Staining in Brain Surgery. A Preliminary Note. Proc R Soc Med (1943) 2.82
Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med (1999) 2.75
Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia (2010) 2.71
Indole-3-Acetic Acid Biosynthesis in the Mutant Maize orange pericarp, a Tryptophan Auxotroph. Science (1991) 2.70
Linkage of type 2 diabetes to the glucokinase gene. Lancet (1992) 2.64
Thrombolysis in patients with diabetes. BMJ (1995) 2.61
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials. Diabetologia (2012) 2.53
Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med (1988) 2.43
Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at -20 degrees C. Clin Chem (1992) 2.41
Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40
Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med (2009) 2.38
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia (2006) 2.37
Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia. Arch Dis Child (1981) 2.36
Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36
Recent advances in the monitoring and management of diabetic ketoacidosis. QJM (2004) 2.33
Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab (2002) 2.30
Persisting mortality in diabetic ketoacidosis. Diabet Med (1993) 2.28
Prevalence and projections of diabetes and pre-diabetes in adults in Sri Lanka--Sri Lanka Diabetes, Cardiovascular Study (SLDCS). Diabet Med (2008) 2.26
Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med (1979) 2.25
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab (2009) 2.23
Home blood sampling for plasma glucose assay in control of diabetes. Br Med J (1978) 2.22
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med (1998) 2.20
Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45). UK Prospective Diabetes Study Group. Diabet Med (2000) 2.20
Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia (2009) 2.16
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15
Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism (1979) 2.07
Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Clin Chim Acta (1997) 2.01
Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. Diabetes (1999) 1.97
Survival in sinoatrial disorder (sick-sinus syndrome). Br Med J (1980) 1.94
Hypoglycaemia in African children with severe malaria. Lancet (1987) 1.88
Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) (1986) 1.87
Acute metabolic response to human growth hormone in different types of dwarfism. Br Med J (1967) 1.86
Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) (1999) 1.85
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts. Diabetologia (2012) 1.83
Very pure porcine insulin in clinical practice. Br Med J (1979) 1.81